BusinessAssembly Biosciences Presents Clinical Data at Drug Formulation & Bioavailability Summit Showing Its Oral Gemicel(TM) Technology Achieves Targeted Delivery to the Lower GI TractBy Nasdaq OMXJan 27, 2016, 12:30 PM UTC